An overview of benefits and risks of chronic melanocortin-1 receptor activation.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- An overview of benefits and risks of chronic melanocortin-1 receptor activation.
- Published In:
- Journal of the European Academy of Dermatology and Venereology : JEADV, 39(1), 39-51 (2025)
- Authors:
- Böhm, M, Robert, C, Malhotra, S, Clément, K, Farooqi, S
- Database ID:
- RPEP-10261
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10261APA
Böhm, M; Robert, C; Malhotra, S; Clément, K; Farooqi, S. (2025). An overview of benefits and risks of chronic melanocortin-1 receptor activation.. Journal of the European Academy of Dermatology and Venereology : JEADV, 39(1), 39-51. https://doi.org/10.1111/jdv.20269
MLA
Böhm, M, et al. "An overview of benefits and risks of chronic melanocortin-1 receptor activation.." Journal of the European Academy of Dermatology and Venereology : JEADV, 2025. https://doi.org/10.1111/jdv.20269
RethinkPeptides
RethinkPeptides Research Database. "An overview of benefits and risks of chronic melanocortin-1 ..." RPEP-10261. Retrieved from https://rethinkpeptides.com/research/bohm-2025-an-overview-of-benefits
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.